Literature DB >> 2991565

The placenta as a site of cytomegalovirus infection in guinea pigs.

B P Griffith, S R McCormick, C K Fong, J T Lavallee, H L Lucia, E Goff.   

Abstract

The development of cytomegalovirus (CMV) infection in the placenta was studied in Hartley guinea pigs inoculated at midgestation, and its role in determining the outcome of fetal CMV infection was assessed. A hematogenous spread of CMV from the mother to the placenta occurred early during the course of the infection. However, the virus remained present in placental tissues long after CMV had been cleared from maternal blood (i.e., 3 and 4 weeks postinoculation). At that time, the virus was able to replicate in placental tissues in the presence of specific maternal antibodies. Viral nucleocapsids were seen within nuclei of trophoblastic cells, and virions were present surrounding infected cells. In addition, typical CMV-induced histopathological lesions bearing CMV antigens were consistently localized at the transitional zone between the capillarized labyrinth and the noncapillarized interlobium. Whenever CMV infection of the fetus occurred, virus was isolated from the associated placenta. Among placental-fetal units with CMV-infected placentas, only 27% of the fetuses were found to be infected. In addition, there was a delay in the establishment of the infection in the fetus in relation to the placenta, although frequencies of virus isolation in placental and fetal tissues peaked at 3 weeks after CMV inoculation. These results suggest that during primary CMV infection of pregnant guinea pigs, the placenta not only serves as a reservoir for CMV but also acts to limit transmission of the virus to the fetus.

Entities:  

Mesh:

Year:  1985        PMID: 2991565      PMCID: PMC254947     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Cytomegalovirus viremia with transmission from mother to fetus.

Authors:  M L French; J F Thompson; A White
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

2.  Pathology of the placenta and cord in some viral infections.

Authors:  W A Blanc
Journal:  Major Probl Clin Pediatr       Date:  1978

3.  Experimental congenital infection with cytomegalovirus: a guinea pig model.

Authors:  M L Kumar; G A Nankervis
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

4.  Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission.

Authors:  Y C Choi; G D Hsiung
Journal:  J Infect Dis       Date:  1978-08       Impact factor: 5.226

Review 5.  The guinea-pig placenta.

Authors:  P Kaufmann; M Davidoff
Journal:  Adv Anat Embryol Cell Biol       Date:  1977       Impact factor: 1.231

6.  Immunologic competence of the immature human fetus. Morphologic evidence from intrauterine Cytomegalovirus infection.

Authors:  G Altshuler
Journal:  Obstet Gynecol       Date:  1974-06       Impact factor: 7.661

7.  Placental and fetal manifestations of cytomegalovirus infection.

Authors:  K Benirschke; G R Mendoza; P L Bazeley
Journal:  Virchows Arch B Cell Pathol       Date:  1974

8.  Structural features and quantitative age-dependent changes in the intervascular barrier of the guinea-pig haemochorial placenta.

Authors:  J A Firth; A Farr
Journal:  Cell Tissue Res       Date:  1977-11-23       Impact factor: 5.249

9.  Comparison of guinea pig cytomegalovirus and guinea pig herpes-like virus: growth characteristics and antigentic relationship.

Authors:  G D Hsiung; R B Tenser; C K Fong
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

10.  Guinea pig cytomegalovirus: transplacental transmission. Brief report.

Authors:  K P Johnson; W S Connor
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

View more
  48 in total

1.  Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection.

Authors:  Fernando J Bravo; David I Bernstein; James R Beadle; Karl Y Hostetler; Rhonda D Cardin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

Authors:  M R Schleiss; A McGregor; N J Jensen; G Erdem; L Aktan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

3.  A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2021-03-17       Impact factor: 3.891

4.  Mixed infection and strain diversity in congenital cytomegalovirus infection.

Authors:  Shannon A Ross; Zdenek Novak; Sunil Pati; Raj Kumar Patro; Jennifer Blumenthal; Vishwanath R Danthuluri; Amina Ahmed; Marian G Michaels; Pablo J Sánchez; David I Bernstein; Robert W Tolan; April L Palmer; William J Britt; Karen B Fowler; Suresh B Boppana
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

5.  Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus.

Authors:  G Halwachs-Baumann; M Wilders-Truschnig; G Desoye; T Hahn; L Kiesel; K Klingel; P Rieger; G Jahn; C Sinzger
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 6.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

7.  Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.

Authors:  R C Brady; M R Schleiss
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

9.  Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

10.  An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.

Authors:  Mark R Schleiss; Ryan Buus; K Yeon Choi; Alistair McGregor
Journal:  Future Virol       Date:  2013-12-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.